跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈在新的选项卡/窗口中打开

Elsevier
通过我们出版

Progress in Biochemistry and Biotechnology

Aim & scope

The Progress in Biochemistry and Biotechnology series is a new venture that aims to provide a comprehensive suite of reference books on developing areas in biochemistry and biotechnology. Chapters written by experts worldwide will introduce practical aspects and best methods, will explain the fundamental biochemistry knowledge, and will provide forward-looking perspectives. Ultimately, the series aims to aid postgraduate students and researchers apply biochemical and biotechnological tools and understand current challenges in the field.

The books will provide a valuable reference for scientists working outside their own area of current expertise or looking to engage in biochemistry. Coverage will include topics such as clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease, biochemical physiology, primarily bioenergetics/energy metabolism, cell biology, cellular stress responses, enzymology, intermediary metabolism, macromolecular structure and function, gene regulation, evolutionary genetics. Most volumes will focus on biochemical or molecular analyses that have clear ramifications for physiological processes.

Progress in Biochemistry and Biotechnology

Audience

Academicians, researchers and (post) graduate students engaged in these major research streams of biochemistry like science, technology and medicine and other stakeholders such as policy makers, industrial leaders, professionals.